ICATIBANT
NDC 69097-664, ICATIBANT, injection, from Cipla USA Inc..
- Product NDC
- 69097-664
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212446
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICATIBANT ACETATE30 mg/3mL
Pharmacologic classes
Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-664-34 | 69097066434 | 1 SYRINGE, GLASS in 1 CARTON (69097-664-34) / 3 mL in 1 SYRINGE, GLASS |
| 69097-664-68 | 69097066468 | 3 SYRINGE, GLASS in 1 CARTON (69097-664-68) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ccbb5e50-ce56-4898-aa1a-f1c1f3d312f6
Use it
Look up 69097-664 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-664 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.